← All trials
NCT01792310
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2013
- Primary completion
- Sep 1, 2016
- Completion date
- Sep 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 54
- Arms / groups
- 9 / —
- Source
- AACT · pre-existing
Sponsors
- Lipopharma Therapeutics SLLead sponsor
- Specialized Medical Services, Oncology BVCollaborator
- Universidad Autonoma de BarcelonaOverall official - principal investigator
- Universidad Autonoma de BarcelonaCollaborator
- Royal Marsden Hospital NHS TrustCollaborator
- University of LondonStudy chair
- University of LondonOverall official - principal investigator
- Newcastle UniversityOverall official - principal investigator
- Newcastle UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.